Manta MedTech Osmotic Drug Chamber System with Fixed Dose Size for Wearable Medical Devices
Summary
USPTO published patent application US20260097165A1 for Manta MedTech LLC's osmotic drug chamber system with fixed dose size designed for active wearable medical devices. The system incorporates an osmotic chamber with osmotic agent, permeability module for fluid ingress, drug chamber, compressible piston for longitudinal movement, valve module regulating drug release, fluid chamber with semipermeable membrane, and drug delivery outlets. The filing date was December 11, 2025.
What changed
USPTO published patent application US20260097165A1 for Manta MedTech LLC covering an osmotic drug chamber system for active wearable medical devices. The technology comprises an osmotic chamber containing an osmotic agent, a permeability module enabling fluid ingress, a drug chamber holding pharmaceutical compounds, a compressible piston positioned between chambers that moves longitudinally during operation, a valve module controlling drug release, a fluid chamber with semipermeable membrane, and external delivery channels. The piston advances toward the drug chamber when a valve opens for drug release and retracts when the valve closes, driven by osmotic pressure.
Medical device manufacturers and pharmaceutical companies developing wearable drug delivery systems should review this patent application for potential freedom-to-operate concerns. If granted, the patent would provide Manta MedTech LLC with exclusive rights to the osmotic drug delivery technology described, potentially affecting competitive development of similar wearable drug delivery devices.
What to do next
- Monitor for patent grant status
- Review patent claims for potential infringement concerns
- Consult intellectual property counsel if developing similar drug delivery technology
Archived snapshot
Apr 13, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEM FOR DRUG DELIVERY WITH FIXED DOSE SIZE
Application US20260097165A1 Kind: A1 Apr 09, 2026
Assignee
Manta MedTech LLC
Inventors
Raju S. DAVE, Xing SU, Himanshu VERMA, Ashish Shah, Kenta Alten
Abstract
Embodiments relate to systems comprising Active Wearable Medical Device (AWMD) with an osmotic chamber containing or configured to receive an osmotic agent, a permeability module for fluid ingress, and a drug chamber holding a drug. A compressible piston, positioned between the chambers, moves longitudinally as a whole during operation. The compressible piston advances toward the drug chamber when a valve opens, enabling drug release through one or more outlets, and retracts when the valve closes, driven by osmotic pressure. A valve module regulates this flow. The system also comprises a fluid chamber containing fluid and a semipermeable membrane coupling it to the AWMD. A channel connected to the drug outlets delivers the drug externally.
CPC Classifications
A61M 5/14248 A61M 5/1409 A61M 5/14526 A61M 2202/0007 A61M 2205/0216 A61M 2205/3327 A61M 2205/3334 A61M 2209/088 A61M 2210/04
Filing Date
2025-12-11
Application No.
19416189
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.